Eve Burstein
Stock Analyst at Bernstein
(2.24)
# 2,652
Out of 4,826 analysts
22
Total ratings
38.46%
Success rate
2.29%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $135 → $145 | $108.37 | +33.80% | 3 | Jan 10, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $157.23 | +27.20% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $92.89 | +56.10% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $348.38 | +3.34% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $53.32 | +68.79% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $44.05 | -20.54% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $422.62 | +46.70% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.10 | +127.27% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $12.64 | +74.05% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $78.21 | +41.93% | 1 | Sep 28, 2023 |
Agilent Technologies
Jan 10, 2025
Maintains: Market Perform
Price Target: $135 → $145
Current: $108.37
Upside: +33.80%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $157.23
Upside: +27.20%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $92.89
Upside: +56.10%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $348.38
Upside: +3.34%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $53.32
Upside: +68.79%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $44.05
Upside: -20.54%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $422.62
Upside: +46.70%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.10
Upside: +127.27%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $12.64
Upside: +74.05%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $78.21
Upside: +41.93%